J. Nutt

The role of folate receptor alpha (FRα) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy

A. Razak, J. Lunec, A. Calvert, 2010, British Journal of Cancer.

hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours

J. Lunec, J. Mellon, P. Foster, 2007, British Journal of Cancer.

Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2

J. Lunec, J. Mellon, J. Nutt, 2004, British Journal of Cancer.

Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine

J. Lunec, J. Lunec, J. Mellon, 2003, BJU international.

Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.

J. Lunec, J. Mellon, K. Qureshi, 1998, British Journal of Cancer.

Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker.

G. Scagliotti, R. Plummer, Michael Thomas, 2015, Clinical lung cancer.

Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines.

J. Lunec, D. Gonzalez, K. O'Toole, 2009, European journal of cancer.

Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.

D. Neal, J. Lunec, J. Mellon, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.

D. Neal, J. Lunec, J. Mellon, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells.

J. Lunec, J. Nutt, 1996, European journal of cancer.